[Molecular pathophysiology of MALT lymphoma and strategy for therapy].
Tsuneya
T
Nakamura
Takio
T
Yokoi
Shigeo
S
Nakamura
D017209:Apoptosis / Q000235:genetics; D019677:Artificial Gene Fusion; D020169:Caspases; D002880:Chromosomes, Human, Pair 11 / Q000235:genetics; D002887:Chromosomes, Human, Pair 18 / Q000235:genetics; D003131:Combined Modality Therapy; D016481:Helicobacter Infections / Q000150:complications / Q000188:drug therapy; D016480:Helicobacter pylori; D006801:Humans; D018442:Lymphoma, B-Cell, Marginal Zone / Q000145:classification / Q000209:etiology* / Q000235:genetics / Q000628:therapy*; D000074884:Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein; D009363:Neoplasm Proteins / Q000235:genetics; D009367:Neoplasm Staging; D016879:Salvage Therapy; D014178:Translocation, Genetic
D009363:Neoplasm Proteins; D020169:Caspases; C400109:MALT1 protein, human; D000074884:Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein